Before matching, compared with the CCRT-alone group, more patients in the DC group had chronic obstructive pulmonary disease, had stage IIIA or IIIC, had positive results for PD-L1 expression (PD-L1 TPS ≥ 1%), received carboplatin rather than cisplatin in their paclitaxel-based chemotherapy regimens, and developed radiation pneumonitis. The gene discussed is CD274; the disease is radiation pneumonitis.